Prosecution Insights
Last updated: October 01, 2026

Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

31 pending office actions • 24 art units • 31 examiners • 0 of 31 (0%) have an AI response strategy ready • 37 patents granted in the last 365 days

Analysis

MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. has 2 pending office actions in the Chemistry & Materials technology area. These 2 pending office actions are handled by 2 distinct examiners. This distribution results in an even workload where each examiner manages a single pending matter.

The prosecution is spread across 2 distinct art units. This count of 2 distinct art units matches the number of 2 pending office actions and 2 distinct examiners, suggesting that the pending matters involve different technical sub-specialties. CHOI, WOO H is the busiest examiner, with a busiest examiner pending count of 1. This busiest examiner pending count of 1 accounts for half of the total pending actions.

Practitioners can observe that with 2 pending office actions and 2 distinct art units, the portfolio is technically diverse for its size. The involvement of 2 distinct examiners means the company must navigate two different sets of examiner preferences. The busiest examiner pending count of 1 shows that no single examiner has more influence than another over the current pending matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

31
Total Pending OAs
17
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
2
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (2)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

22
Hard (71%)
8
Medium (26%)
1
Easy (3%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (13%)
§103 only6 (19%)
§102 only1 (3%)
§112 only1 (3%)
Double-patenting + other1 (3%)
Multi-statute (no §101)18 (58%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
52% of docket
0
Information Tech
0% of docket
1
Communications
3% of docket
4
Semiconductors
13% of docket
4
Mechanical / Eng
13% of docket
6
Business / Other
19% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

310 h
Manual time on pending OAs
62 h
Time saved (low, 20%)
108 h
Time saved (mid, 35%)
2.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MONAHAN, MEGAN ELIZABETH 1 58.0% +14.4%
SAIDHA, TEKCHAND 1 82.9% +14.1%
TIWARI, VYOMA SHUBHAM 1 31.5% +48.1%
BOWMAN, ANDREW J 1 65.9% +13.2%
LOUNTOS, GEORGE THEMISTOCLIS 1 57.1% +60.0%
SAMALA, JAGADISHWAR RAO 1 68.0% +55.6%
LEE, SHUN K 1 42.2% +16.3%
SOTO, JANICE M 1 68.7% +14.2%
PHILLIPS, RUFUS L 1 62.6% +32.1%
RHOADES, DEREK JAMES 1 71.3% +17.2%

Hard Cases (22)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17285148 CERVICAL CANCER ORGANOIDS NICOL, ALEXANDER W 52d overdue
17770259 HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY MIDDLETON, DANAYA L 5d overdue
18729559 TEMPERATURE CONTROL SYSTEM, VACUUM SYSTEM, AND METHOD OF ADJUSTING THE TEMPERATURE OF A VACUUM CHAMBER OF A VACUUM SYSTEM BOWMAN, ANDREW J 4d overdue
17275084 AUTOMATED GENERATION AND ANALYSIS OF ORGANOIDS BATES, KEENAN ALEXANDER 13d
18037575 FILTER FITZSIMMONS, ALLISON G 48d
18571926 METHOD OF PREPARING A SURFACE OF A SINGLE CRYSTAL WAFER AS AN EPITAXIAL TEMPLATE, EPITAXIAL TEMPLATE AND DEVICE BRATLAND JR, KENNETH A 76d
19099843 ENDOSCOPE AND METHOD FOR CONTROLLING THE ENDOSCOPE MONAHAN, MEGAN ELIZABETH —
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION SAIDHA, TEKCHAND —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18729559 TEMPERATURE CONTROL SYSTEM, VACUUM SYSTEM, AND METHOD OF ADJUSTING THE TEMPERATURE OF A VACUUM CHAMBER OF A VACUUM SYSTEM BOWMAN, ANDREW J 4d overdue
19099843 ENDOSCOPE AND METHOD FOR CONTROLLING THE ENDOSCOPE MONAHAN, MEGAN ELIZABETH —
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION SAIDHA, TEKCHAND —
18839402 HIGH-CONTRAST EN-BLOC STAINING OF MOUSE WHOLE-BRAIN AND HUMAN BRAIN SAMPLES FOR EM-BASED CONNECTOMICS TIWARI, VYOMA SHUBHAM —
18728493 GLYCOSIDE HYDROLASE AND/OR TRANSGLYCOSYLASE FOR SYNTHESIS OF XYLOSE OLIGOSACCHARIDES LOUNTOS, GEORGE THEMISTOCLIS —
18686456 PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING SAMALA, JAGADISHWAR RAO —
18422370 LOCALIZING A SINGULARIZED FLUOROPHORE MOLECULE BY CONTINUOUSLY MOVING A FOCUSED LIGHT BEAM AROUND THE MOLECULE LEE, SHUN K —
18574608 Method and apparatus for spatially manipulating at least one particle in a fluid, computer program product and computer-readable storage medium SOTO, JANICE M —

Top Art Units

Art UnitApps
1618 2
1717 1
1652 1
2884 1
2877 1
1714 1
2896 1
1624 1
1735 1
1622 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19099843 ENDOSCOPE AND METHOD FOR CONTROLLING THE ENDOSCOPE MONAHAN, MEGAN ELIZABETH — §102§103§112Other Non-Final OA — Pending Jan 30, 2025
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION SAIDHA, TEKCHAND — §102§112 Non-Final OA — Pending Oct 11, 2024
18839402 HIGH-CONTRAST EN-BLOC STAINING OF MOUSE WHOLE-BRAIN AND HUMAN BRAIN SAMPLES FOR EM-BASED CONNECTOMICS TIWARI, VYOMA SHUBHAM — §112 Non-Final OA — Pending Aug 16, 2024
18729559 TEMPERATURE CONTROL SYSTEM, VACUUM SYSTEM, AND METHOD OF ADJUSTING THE TEMPERATURE OF A VACUUM CHAMBER OF A VACUUM SYSTEM BOWMAN, ANDREW J 1717 §102§103§112 Final Rejection 4d overdue Pending Jul 17, 2024
18728493 GLYCOSIDE HYDROLASE AND/OR TRANSGLYCOSYLASE FOR SYNTHESIS OF XYLOSE OLIGOSACCHARIDES LOUNTOS, GEORGE THEMISTOCLIS 1652 §101§112 Non-Final OA — Pending Jul 12, 2024
18686456 PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING SAMALA, JAGADISHWAR RAO — §102§103§112 Non-Final OA — Pending Feb 26, 2024
18422370 LOCALIZING A SINGULARIZED FLUOROPHORE MOLECULE BY CONTINUOUSLY MOVING A FOCUSED LIGHT BEAM AROUND THE MOLECULE LEE, SHUN K 2884 §103§112 Final Rejection — Pending Jan 25, 2024
18574608 Method and apparatus for spatially manipulating at least one particle in a fluid, computer program product and computer-readable storage medium SOTO, JANICE M — §102§103§112Other Non-Final OA — Pending Dec 27, 2023
18574585 Method and apparatus for measuring a force on at least one particle in a fluid, computer program product and computer-readable storage medium PHILLIPS, RUFUS L 2877 §103§112 Non-Final OA — Pending Dec 27, 2023
18573448 CONTINUOUS FLOW PROCESS FOR PRODUCTION OF CATIONIC LIPIDS RHOADES, DEREK JAMES — §103§112 Non-Final OA — Pending Dec 22, 2023
18571926 METHOD OF PREPARING A SURFACE OF A SINGLE CRYSTAL WAFER AS AN EPITAXIAL TEMPLATE, EPITAXIAL TEMPLATE AND DEVICE BRATLAND JR, KENNETH A 1714 §103§112 Final Rejection 76d Pending Dec 19, 2023
18571271 VINYLATED KETO ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING AND SYNTHESIS THEREOF BAEK, JONGHWAN NMN 1618 §103§112 Non-Final OA — Pending Dec 18, 2023
18570870 METHOD FOR PRODUCING A SOLID-STATE COMPONENT, SOLID-STATE COMPONENT, QUANTUM COMPONENT AND APPARATUS FOR PRODUCING A SOLID-STATE COMPONENT REAMES, MATTHEW L 2896 §102§103§112Other Non-Final OA — Pending Dec 15, 2023
18289283 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION SAMSELL, RILLA MARIE 1624 §103§112DP Non-Final OA — Pending Nov 02, 2023
18289128 NETWORK OF METAL FIBERS AND METHOD OF ASSEMBLING A FIBER NETWORK HEVEY, JOHN A 1735 §103 Non-Final OA — Pending Nov 01, 2023
18376875 COMBINED USE OF KETAMINE AND RETIGABINE (EZOGABINE) FOR THE TREATMENT OF PSYCHIATRIC DISORDERS SANCHEZ, JUSTIN CHRISTOPHER 1622 §103§112 Non-Final OA — Pending Oct 05, 2023
18548910 STORAGE SYSTEM FOR CRYO-EM/ ET SAMPLES MOORE, DEVON TYLEN 3763 §102§103 Final Rejection — Pending Sep 04, 2023
18262761 A METHOD FOR FABRICATING A MAGNETIC SPIN VALVE DEVICE COMPRISING FERROMAGNETIC LAYERS WITH NON-COLLINEAR MAGNETIZATIONS KIM, MICHELLE JINJU 2688 §103 Final Rejection 6d Pending Jul 25, 2023
18038622 SENSOR ARRANGEMENT FOR SENSING FORCES AND METHOD FOR FABRICATING A SENSOR ARRANGEMENT PARCO JR, RUBEN C 2853 §102§103§112 Non-Final OA — Pending May 24, 2023
18037575 FILTER FITZSIMMONS, ALLISON G 1773 §102§103 Final Rejection 48d Pending May 18, 2023
18020339 DELIVERY DEVICE HARRIS, WESLEY G 3783 §102 Final Rejection — Pending Feb 08, 2023
18014657 JOINT FOR A DEVICE MOVEABLE IN VACUUM, MECHANISM FOR MOVING A DEVICE IN VACUUM AND DEVICE FERGUSON, MICHAEL P 3619 §103 Final Rejection 6d Pending Jan 05, 2023
17770259 HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY MIDDLETON, DANAYA L 1674 §101§112 Non-Final OA 5d overdue Pending Apr 19, 2022
17602895 COMPREHENSIVE DETECTION OF SINGLE CELL GENETIC STRUCTURAL VARIATIONS ZEMAN, MARY K 1686 §101§102§112Other Non-Final OA — Pending Oct 11, 2021
17293621 SURFACTANT-STABILIZED FLUID INTERFACE AND DISPERSION COMPRISING ONE OR MORE DROPLETS HAVING A SURFACTANT STABILIZED FLUID INTERFACE KASSA, TIGABU 1619 §103 Final Rejection — Pending May 13, 2021
17285148 CERVICAL CANCER ORGANOIDS NICOL, ALEXANDER W 1634 §103§112 Final Rejection 52d overdue Pending Apr 14, 2021
17282747 USE OF A SUBSTITUTED OR UNSUBSTITUTED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND FOR HIGH-RESOLUTION MICROSCOPY ADAMS, MICHELLE 1797 §102§112Other Final Rejection — Pending Apr 02, 2021
17275084 AUTOMATED GENERATION AND ANALYSIS OF ORGANOIDS BATES, KEENAN ALEXANDER 1631 §103§112 Non-Final OA 13d Pending Mar 10, 2021
16641059 SLIPPERY MICROPROPELLERS PENETRATE THE VITREOUS HUMOR VU, JAKE MINH 1618 §103 Final Rejection — Pending Feb 21, 2020
16617348 MAGNETICALLY ACTUATED CAPSULE ENDOSCOPE, MAGNETIC FIELD GENERATING AND SENSING APPARATUS AND METHOD OF ACTUATING A MAGNETICALLY ACTUATED CAPSULE ENDOSCOPE TOWA, RENE T 3791 §103 Final Rejection — Pending Nov 26, 2019
18007990 STABILIZATION OF 1,2,4-TRIOXANE COMPOUNDS BY CHLOROGENIC ACIDS LANDAU, SHARMILA GOLLAMUDI 1600 §101§102§103DP Final Rejection — Pending Dec 02, 2022

Managing Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month